From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 1,593,128 shares, representing 2.11% for $0.89 million under the buyback announced on June 15, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4071 USD | -10.17% |
|
-9.53% | -80.04% |
May. 14 | Transcript : The Oncology Institute, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | The Oncology Institute, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-80.04% | 32.83M | |
+25.21% | 88.77B | |
-22.28% | 77.04B | |
+3.24% | 26.87B | |
-9.70% | 17.3B | |
0.00% | 16.89B | |
+0.78% | 15.44B | |
+77.65% | 13.11B | |
+70.99% | 13.15B | |
-23.68% | 13.16B |
- Stock Market
- Equities
- TOI Stock
- News The Oncology Institute, Inc.
- Tranche Update on The Oncology Institute, Inc.'s Equity Buyback Plan announced on June 15, 2023.